Insider Shareholders with Direct Ownership of Acceleron Pharma Inc (XLRN)
This section provides a comprehensive overview of the insiders with direct ownership of Acceleron Pharma Inc (XLRN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ACCELERON PHARMA INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Celgene Corp /De/
> 10% Shareholder |
147,087 | 2,241 | 7,008,510 | 3 |
Jul 09, 2020
Reduced 0.03%
|
|
Francois Nader
Director |
1,622 | 6,749 | 0 | 2 |
Nov 19, 2021
Reduced 100.0%
|
|
Thomas A Mccourt
Director |
9,122 | 13,544 | 0 | 4 |
Nov 19, 2021
Reduced 100.0%
|
|
Sujay Kango
EVP, Chief Commercial Officer |
20,409 | 45,753 | 0 | 10 |
Nov 19, 2021
Reduced 100.0%
|
|
Laura Hamill
Director |
474 | 474 | 0 | 2 |
Nov 19, 2021
Reduced 100.0%
|
|
Habib J Dable
CEO and President |
116,662 | 205,986 | 0 | 8 |
Nov 19, 2021
Reduced 100.0%
|
|
Jay T. Backstrom
EVP, Research and Development |
5,409 | 22,968 | 0 | 3 |
Nov 19, 2021
Reduced 100.0%
|
|
Terrence C Kearney
Director |
39,122 | 44,249 | 0 | 4 |
Nov 19, 2021
Reduced 100.0%
|
|
Christopher Hite
Director |
930 | 930 | 0 | 2 |
Nov 19, 2021
Reduced 100.0%
|
|
Karen L. Smith
Director |
19,472 | 22,411 | 0 | 6 |
Nov 19, 2021
Reduced 100.0%
|
|
Kevin F Mclaughlin
SVP, CFO and Treasurer |
79,868 | 91,084 | 0 | 16 |
Nov 19, 2021
Reduced 100.0%
|
|
Joseph S Zakrzewski
Director |
21,622 | 54,499 | 0 | 6 |
Nov 19, 2021
Reduced 100.0%
|
|
Adam M Veness
SVP, General Counsel and Sec. |
16,018 | 35,179 | 0 | 11 |
Nov 19, 2021
Reduced 100.0%
|
|
Kemal Malik
Director |
1,622 | 1,622 | 0 | 2 |
Nov 19, 2021
Reduced 100.0%
|